```
REGISTERED CHARITY NUMBER: 1142966
```
## **`Report of the Trustees and`**
```
Unaudited Financial Statements
```
```
for the Year Ended 31 March 2023
```
```
for
```
## **`BRITISH MYOLOGY SOCIETY`**
```
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
```
## **`BRITISH MYOLOGY SOCIETY`**
```
Contents of the Financial Statements
for the Year Ended 31 March 2023
```
||**`Page`**|
|---|---|
|**`Report of the Trustees`**|`1 to 2`|
|**`Independent Examiner's Report`**|`3`|
|**`Statement of Financial Activities`**|`4`|
|**`Balance Sheet`**|`5`|
|**`Notes to the Financial Statements`**|`6 to 10`|
|**`Detailed Statement of Financial Activities`**|`11`|
## **`BRITISH MYOLOGY SOCIETY`**
## **`Report of the Trustees`**
## **`for the Year Ended 31 March 2023`**
```
Thetrusteespresenttheirreportwiththefinancialstatementsofthecharityfortheyear ended
31March2023.ThetrusteeshaveadoptedtheprovisionsofAccountingandReportingby Charities:
StatementofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsinaccordance with
the FinancialReportingStandardapplicablein the UK and Republicof Ireland(FRS 102)(effective1 January
2019).
```
## **`OBJECTIVES AND ACTIVITIES`**
## **`Purposes and aims`**
```
TheSociety'spurposeistoactasamultidisciplinaryprofessionalbodyofexpertstopromotethe clinical
practice,educationandclinicaltrialsinrelationtomuscledisease,myastheniagravisandspinal muscular
atrophy. It is intended to be a forum of consultant level experts to consider these issues.
```
```
The aims of the Society are:
```
- `agreeing best practice and standards of care for patients with muscle disease`
- `agreeing standards for training in clinical myology and clinical muscle pathology`
- `promoting translational research`
- `establishing clinical networks to facilitate and promote clinical trials and patient registries`
- `facilitating collaborations with patient organisations`
## **`ACHIEVEMENT AND PERFORMANCE`**
## **`Charitable activities`**
```
TheBMSAnnualMeetingwasheldasafull,physicalmeetinginOxfordonthe14thand15thSept 2022.
This meeting included an AGM.
```
```
TheBMSheavilysubsidisedmeetingplacesforallattendees.BMSmembershipwasrequired for
registration.
```
```
The event was well received with excellent attendeeship and feedback.
Attendeeship was around 80 delegates
```
```
The BMS Adult Muscle teaching day was held online on 14th Nov 2022.
```
```
Freeplaces(fundedbytheBMS)wereofferedtotraineesandAHPs.Atotalof65freeplaces were
awarded.
```
```
BMS website address is https://www.britishmyologysociety.org/
```
```
TheBMShasdevelopedanew,onlineeventfor2023:theBMSMuscleMRIworkshop,whichwillrun in
November 2023. This event is available to both BMS members and Non-members.
```
```
Page 1
```
## **`BRITISH MYOLOGY SOCIETY`**
## **`Report of the Trustees`**
```
for the Year Ended 31 March 2023
```
## **`FUTURE PLANS`**
```
TheBMSplanstoruntheAnnualMeetingandthePaediatricMuscleTeachingDayinSept2024 at
Worcester College, Oxford.
```
```
The BMS plans to run an online Allied Health Professional Teaching Day in 2024 (dates to be confirmed)
```
## **`STRUCTURE, GOVERNANCE AND MANAGEMENT`**
## **`Governing document`**
```
Thecharityiscontrolledbyitsgoverningdocument,adeedoftrustandconstitutesan unincorporated
charity.
```
```
The Society was registered as a charity on 19 July 2011.
```
## **`REFERENCE AND ADMINISTRATIVE DETAILS`**
## **`Registered Charity number`**
```
1142966
```
## **`Principal address`**
```
Box 102
National Hospital for Neurology and
Neurosurgery, Queen Square
London
WC1N 3BG
```
## **`Trustees`**
```
Professor M G Hanna
Professor F Muntoni
Dr R Quinlivan
```
## **`Independent Examiner`**
```
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
```
```
Approved by order of the board of trustees on 26 October 2023 and signed on its behalf by:
```
```
Dr R Quinlivan - Trustee
```
```
Page 2
```
```
Independent Examiner's Report to the Trustees of
British Myology Society
```
## **`Independent examiner's report to the trustees of British Myology Society`**
```
I reportto the charitytrusteeson my examinationof the accountsof BritishMyologySociety(the Trust) for
the year ended 31 March 2023.
```
## **`Responsibilities and basis of report`**
```
AsthecharitytrusteesoftheTrustyouareresponsibleforthepreparationoftheaccountsin accordance
with the requirements of the Charities Act 2011 ('the Act').
```
```
I reportin respectof myexaminationof theTrust'saccountscarriedoutunderSection145of theAct and
incarryingoutmyexaminationIhavefollowedallapplicableDirectionsgivenbytheCharity Commission
under Section 145(5)(b) of the Act.
```
## **`Independent examiner's statement`**
```
Ihavecompletedmyexamination.Iconfirmthatnomaterialmattershavecometomyattention in
connection with the examination giving me cause to believe that in any material respect:
```
`1. accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or`
`2. the accounts do not accord with those records; or`
`3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.`
```
Ihavenoconcernsandhavecomeacrossnoothermattersinconnectionwiththeexaminationto which
attentionshouldbedrawninthisreportinordertoenableaproperunderstandingoftheaccountsto be
reached.
```
```
Mr Ryan Cottington, ACA, FCCA
```
```
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
```
```
26 October 2023
```
```
Page 3
```
## **`BRITISH MYOLOGY SOCIETY`**
## **`Statement of Financial Activities for the Year Ended 31 March 2023`**
|**`2023`**
**`Unrestricted`**
**`fund`**
`Notes`
**`£`**
**`INCOME AND ENDOWMENTS FROM`**
`Donations and legacies`
**`3,125`**
**`Charitable activities`**
`Educational and academic`
**`51,265`**
**`Total`**
**`54,390`**
**`EXPENDITURE ON`**
`Raising funds`
`2`
**`-`**
**`Charitable activities`**
`Educational and academic`
**`24,970`**
`Other`
**`42,032`**
**`Total`**
**`67,002`**
**`NET INCOME/(EXPENDITURE)`**
**`(12,612)`**
**`RECONCILIATION OF FUNDS`**
`Total funds brought forward`
**`27,024`**
**`TOTAL FUNDS CARRIED FORWARD`**
**`14,412`**|`2022`
`Total`
`funds`
`£`
`3,223`
`44,890`
`48,113`
`120`
`(90)`
`34,848`
`34,878`
`13,235`
`13,789`
`27,024`|
|---|---|
```
The notes form part of these financial statements
```
```
Page 4
```
## **`BRITISH MYOLOGY SOCIETY`**
## **`Balance Sheet`**
## **`31 March 2023`**
|**`2023`**
**`Unrestricted`**
**`fund`**
`Notes`
**`£`**
**`CURRENT ASSETS`**
`Prepayments and accrued income`
**`18,202`**
`Cash at bank`
**`36,183`**
**`54,385`**
**`CREDITORS`**
`Amounts falling due within one year`
`5`
**`(39,973)`**
**`NET CURRENT ASSETS`**
**`14,412`**
**`TOTAL ASSETS LESS CURRENT LIABILITIES`**
**`14,412`**
**`NET ASSETS`**
**`14,412`**
**`FUNDS`**
`6`
`Unrestricted funds`
**`14,412`**
**`TOTAL FUNDS`**
**`14,412`**|`2022`
`Total`
`funds`
`£`
`8,762`
`51,012`
`59,774`
`(32,750)`
`27,024`
`27,024`
`27,024`
`27,024`
`27,024`|
|---|---|
```
ThefinancialstatementswereapprovedbytheBoardofTrusteesandauthorisedforissue on
26 October 2023 and were signed on its behalf by:
```
```
R Quinlivan - Trustee
```
```
The notes form part of these financial statements
```
```
Page 5
```
```
BRITISH MYOLOGY SOCIETY
```
```
Notes to the Financial Statements
for the Year Ended 31 March 2023
```
## **`1. ACCOUNTING POLICIES`**
## **`Basis of preparing the financial statements`**
```
Thefinancialstatementsofthecharity,whichisapublicbenefitentityunderFRS102,have been
preparedinaccordancewiththeCharitiesSORP(FRS102)'AccountingandReportingby Charities:
StatementofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsin accordance
withtheFinancialReportingStandardapplicableintheUKandRepublicofIreland(FRS 102)
(effective1January2019)',FinancialReportingStandard102'TheFinancialReporting Standard
applicableintheUKandRepublicofIreland'andtheCharitiesAct2011.Thefinancial statements
have been prepared under the historical cost convention.
```
## **`Income`**
```
Allincomeis recognisedin theStatementofFinancialActivitiesoncethecharityhasentitlement to
the funds, it is probable that the income will be received and the amount can be measured reliably.
```
## **`Expenditure`**
```
Liabilitiesarerecognisedasexpenditureassoonasthereisalegalorconstructive obligation
committingthe charityto that expenditure,it is probablethat a transferof economicbenefitswill be
requiredinsettlementandtheamountoftheobligationcanbemeasuredreliably.Expenditure is
accountedforonanaccrualsbasisandhasbeenclassifiedunderheadingsthataggregateall cost
relatedtothecategory.Wherecostscannotbedirectlyattributedtoparticularheadingsthey have
been allocated to activities on a basis consistent with the use of resources.
```
## **`Taxation`**
```
The charity is exempt from tax on its charitable activities.
```
## **`Fund accounting`**
```
Unrestrictedfundscanbe usedin accordancewiththecharitableobjectivesat thediscretionof the
trustees.
```
```
Restrictedfunds can only be used for particularrestrictedpurposeswithin the objectsof the charity.
Restrictionsarisewhenspecifiedbythedonororwhenfundsareraisedforparticular restricted
purposes.
```
```
Furtherexplanationofthenatureandpurposeofeachfundis includedin thenotestothe financial
statements.
```
```
continued...
```
```
Page 6
```
## **`BRITISH MYOLOGY SOCIETY`**
## **`Notes to the Financial Statements - continued for the Year Ended 31 March 2023`**
## **`2. RAISING FUNDS`**
|**`Raising donations and legacies`**||||
|---|---|---|---|
||**`2023`**||`2022`|
||**`£`**||`£`|
|`Support costs`||**`-`**|`120`|
## **`3. TRUSTEES' REMUNERATION AND BENEFITS`**
```
Therewerenotrustees'remunerationorotherbenefitsfortheyearended31March2023nor for
the year ended 31 March 2022.
```
## **`Trustees' expenses`**
```
Therewerenotrustees'expensespaidfortheyearended31March2023norfortheyear ended
31 March 2022.
```
## **`4. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES`**
||`Unrestricted`|
|---|---|
||`fund`|
||`£`|
|**`INCOME AND ENDOWMENTS FROM`**||
|`Donations and legacies`|`3,223`|
|**`Charitable activities`**||
|`Educational and academic`|`44,890`|
|**`Total`**|`48,113`|
|**`EXPENDITURE ON`**||
|`Raising funds`|`120`|
|**`Charitable activities`**||
|`Educational and academic`|`(90)`|
|`Other`|`34,848`|
|**`Total`**|`34,878`|
|**`NET INCOME`**|`13,235`|
|**`RECONCILIATION OF FUNDS`**||
|`Total funds brought forward`|`13,789`|
```
continued...
```
```
Page 7
```
```
Notes to the Financial Statements - continued
for the Year Ended 31 March 2023
```
## **`BRITISH MYOLOGY SOCIETY`**
## **`4. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued`**
|||||`Unrestricted`|
|---|---|---|---|---|
|||||`fund`|
|||||`£`|
||**`TOTAL FUNDS CARRIED FORWARD`**|||`27,024`|
|**`5.`**|**`CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`**||||
||||**`2023`**|`2022`|
||||**`£`**|`£`|
||`Other creditors`||**`39,973`**|`32,750`|
|**`6.`**|**`MOVEMENT IN FUNDS`**||||
||||`Net`||
||||`movement`|`At`|
|||`At 1/4/22`|`in funds`|`31/3/23`|
|||`£`|`£`|`£`|
||**`Unrestricted funds`**||||
||`General fund`|**`27,024`**|**`(12,612)`**|**`14,412`**|
||**`TOTAL FUNDS`**|**`27,024`**|**`(12,612)`**|**`14,412`**|
||`Net movement in funds, included in the above are as follows:`||||
|||`Incoming`|`Resources`|`Movement`|
|||`resources`|`expended`|`in funds`|
|||`£`|`£`|`£`|
||**`Unrestricted funds`**||||
||`General fund`|**`54,390`**|**`(67,002)`**|**`(12,612)`**|
||**`TOTAL FUNDS`**|**`54,390`**|**`(67,002)`**|**`(12,612)`**|
```
continued...
```
```
Page 8
```
```
Notes to the Financial Statements - continued
for the Year Ended 31 March 2023
```
## **`BRITISH MYOLOGY SOCIETY`**
## **`6. MOVEMENT IN FUNDS - continued`**
## **`Comparatives for movement in funds`**
|||`Net`||
|---|---|---|---|
|||`movement`|`At`|
||`At 1/4/21`|`in funds`|`31/3/22`|
||`£`|`£`|`£`|
|**`Unrestricted funds`**||||
|`General fund`|`13,789`|`13,235`|`27,024`|
|**`TOTAL FUNDS`**|`13,789`|`13,235`|`27,024`|
```
Comparative net movement in funds, included in the above are as follows:
```
|**`Unrestricted funds`**
`General fund`
**`TOTAL FUNDS`**|`Incoming`
`Resources`
`Movement`
`resources`
`expended`
`in funds`
`£`
`£`
`£`
`48,113`
`(34,878)`
`13,235`
`48,113`
`(34,878)`
`13,235`|
|---|---|
```
A current year 12 months and prior year 12 months combined position is as follows:
```
|||`Net`||
|---|---|---|---|
|||`movement`|`At`|
||`At 1/4/21`|`in funds`|`31/3/23`|
||`£`|`£`|`£`|
|**`Unrestricted funds`**||||
|`General fund`|`13,789`|`623`|`14,412`|
|**`TOTAL FUNDS`**|`13,789`|`623`|`14,412`|
```
continued...
```
```
Page 9
```
```
Notes to the Financial Statements - continued
for the Year Ended 31 March 2023
```
## **`BRITISH MYOLOGY SOCIETY`**
## **`6. MOVEMENT IN FUNDS - continued`**
```
Acurrentyear12monthsandprioryear12monthscombinednetmovementinfunds,included in
the above are as follows:
```
||`Incoming`|`Resources`|`Movement`|
|---|---|---|---|
||`resources`|`expended`|`in funds`|
||`£`|`£`|`£`|
|**`Unrestricted funds`**||||
|`General fund`|`102,503`|`(101,880)`|`623`|
|**`TOTAL FUNDS`**|`102,503`|`(101,880)`|`623`|
## **`7. RELATED PARTY DISCLOSURES`**
```
There were no related party transactions for the year ended 31 March 2023.
```
```
Page 10
```
## **`BRITISH MYOLOGY SOCIETY`**
## **`Detailed Statement of Financial Activities for the Year Ended 31 March 2023`**
|**`INCOME AND ENDOWMENTS`**
**`Donations and legacies`**
`Subscriptions`
**`Charitable activities`**
`Conferences`
`Sponsorships`
**`Total incoming resources`**
**`EXPENDITURE`**
**`Charitable activities`**
`Conference costs`
**`Support costs`**
**`Management`**
`Postage and stationery`
`Advertising`
`Sundries`
**`Governance costs`**
`Secretarial costs`
`Accountancy and legal fees`
`Computer costs`
`Total resources expended`
**`Net (expenditure)/income`**|`2023`
`£`
**`3,125`**
**`7,015`**
**`44,250`**
**`51,265`**
**`54,390`**
**`24,970`**
**`860`**
**`619`**
**`82`**
**`1,561`**
**`39,273`**
**`1,198`**
**`-`**
**`40,471`**
**`67,002`**
**`(12,612)`**|`2022`
`£`
`3,223`
`945`
`43,945`
`44,890`
`48,113`
`(90)`
`500`
`-`
`120`
`620`
`31,500`
`1,248`
`1,600`
`34,348`
`34,878`
`13,235`|
|---|---|---|
```
This page does not form part of the statutory financial statements
```
```
Page 11
```